康德莱：控股股东拟协议转让公司5%股份引入战略投资者

Group 1 - The core point of the article is that Kangdelai (603987) announced a share transfer agreement with Changsha Medical Investment Co., Ltd., where the controlling shareholder will transfer 21.8395 million shares, representing 5% of the total share capital, at a price of 10.81 yuan per share, totaling 236 million yuan [1] - The share transfer aims to deepen the strategic layout of Kangdelai Group and is expected to enhance the company's governance and optimize its equity structure [1] - The strategic implementation is anticipated to provide the company with industrial and resource synergies from the strategic partner, expanding its development space in the consumer healthcare sector [1]